Home › High Blood Pressure › North Carolina
High Blood Pressure clinical trials in North Carolina
23 studies for High Blood Pressure are looking for participants at sites in North Carolina.
Cities in North Carolina
- Durham10 studies
- Charlotte9 studies
- Winston-Salem7 studies
- Greenville4 studies
- Havelock3 studies
- Wilmington3 studies
- Raleigh3 studies
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Cary Cardiology, Cary
- The University of North Carolina at Chapel Hill, Chapel Hill
- Physicians East, PA, Greenville
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07064473A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Medication Management, Greensboro
- Monroe Biomedical Research, Monroe
- West Clinical Research, Morehead City
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07794579A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Greenville
- Research Site, Hickory
- Research Site, Jacksonville
- and 10 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
- NC Heart and Vascular, Raleigh
Recruiting
Ages 22 to 75 · All sexes · Updated Sep 24, 2026 · NCT06559891BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
- HCA Asheville Cardiology Associates, Asheville
- Atrium Health - Sanger Heart, Charlotte
- WakeMed, Raleigh
Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06059638Lifestyle Intervention In CKD
- Sarah W Stedman Nutrition & Metabolism Center, Durham
Recruiting
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07633145Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Durham
- Clinical Trial Site, Greenville
- Clinical Trial Site, High Point
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
- Retension Clinical Site, Asheboro
- Retension Clinical Site, Charlotte
- Retension Clinical Site, Monroe
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Sep 10, 2026 · NCT07142356Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Duke University Health System, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 0 to 20 · All sexes · Updated Aug 21, 2026 · NCT04278404Global Paradise System US Post Approval Study
- University of North Carolina at Chapel Hill School of Medicine, Chapel Hill
- Durham VA Health System, Durham
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT06297291An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
- Monroe Biomedical Research, Monroe
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 30, 2026 · NCT07543120A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Monroe Biomedical Research, Monroe
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07610278SPYRAL GEMINI Pilot Study
- University of North Carolina (UNC) Memorial Hospital, Chapel Hill
Recruiting
Ages 18 to 80 · All sexes · Updated Jun 24, 2026 · NCT06907147'Eat Well' Produce Prescription RCT
- Durham VA Health Care System, Durham
Recruiting
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT07534501Remote Hypertension Management for Black Patients
- Wake Forest University Health Sciences, Winston-Salem
Recruiting
Ages 21 to 85 · All sexes · Updated Jun 2, 2026 · NCT06527794Low Energy Availability and Hypertension in Division I HBCU Athletes
- North Carolina Agricultural & Technical State University, Greensboro
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 26 · All sexes · Updated May 13, 2026 · NCT07583940Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity
- Wake Forest University Health Sciences, Winston-Salem
Recruiting
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT07031739Telehealth and Remote Blood Pressure
- Wake Forest University Health Sciences, Winston-Salem
Recruiting
Ages 18 to 45 · Women · Updated Apr 27, 2026 · NCT07356518Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
- Vanda Investigative Site, Kinston
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Feb 27, 2026 · NCT07090161Improving Hypertension Control in Rheumatoid Arthritis
- Duke Health System, Durham
Recruiting
Ages 18 and older · All sexes · Updated Feb 6, 2026 · NCT05760898RCT of Sensor-controlled Digital Game for Hypertension Self-care in a Native American Community
- University of North Carolina Chapel Hill, Chapel Hill
Recruiting
Ages 18 and older · All sexes · Updated Jan 21, 2026 · NCT05671406Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
- Wake Forest Health Sciences, Winston-Salem
RecruitingObservational studyHealthy volunteers welcome
Ages 7 to 18 · All sexes · Updated Dec 11, 2025 · NCT04752293Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
- Duke University - Charlotte Study Sites, Charlotte
- Duke University - Duke Study Site, Durham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 24, 2025 · NCT05129345From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.